Creative Medical Technology Holdings, Inc. (CELZ) vs Curis, Inc. (CRIS)
A side-by-side comparison of Creative Medical Technology Holdings, Inc. and Curis, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELZ
Creative Medical Technology Holdings, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 9:32 AM EDT
CRIS
Curis, Inc.
$0.76HealthcareDelayed quote: Oct 6, 2026, 9:31 AM EDT
Total return — CELZ vs CRIS
growth of $100 · dividends reinvested · last 10yCELZ -100.0% (-72.6%/yr)CRIS -100.0% (-59.1%/yr)CRIS compounded faster over this window
Log scale — wide-divergence pair
CELZ CRIS
CELZ vs CRIS: by the numbers
- •CELZ is the larger company ($2M vs $1M market cap).
- •Both run net losses; CRIS's is the smaller (-490.33% vs -201355.37% net margin).
- •Both shrank revenue over the past five years; CRIS's decline was smaller (-15.88% vs -50.85% CAGR).
Metrics side by side
Valuation
| Metric | CELZ | CRIS |
|---|---|---|
| P/S ratio | 774.46 | 0.34 |
| P/B ratio | 0.27 | 0.31 |
Profitability
| Metric | CELZ | CRIS |
|---|---|---|
| Gross margin | 63.43% | 99.28% |
| Operating margin | -102380.23% | -348.43% |
| Net margin | -201355.37% | -490.33% |
| ROE | -69.79% | -450.54% |
| ROIC | -71.90% | -567.17% |
Growth (annualized)
| Metric | CELZ | CRIS |
|---|---|---|
| Revenue CAGR (5Y) | -50.85% | -15.88% |
| Total return CAGR (5Y) | -57.96% | -81.06% |
Frequently asked
- Which has grown faster, CELZ or CRIS?
- Neither grew: over the past five years both shrank revenue, with CRIS's decline the smaller — CELZ at a -50.85% CAGR versus CRIS at -15.88%.
- How have CELZ and CRIS total returns compared?
- Over the past 10 years, CELZ delivered -72.19% and CRIS delivered -59.09% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.